Ultrasound
DeviceUltrasound of lungs
NCT Number: NCT06140615
The goal of this clinical trial is to determine whether lung ultrasound can predict extubation success in neonates with respiratory distress.
Participants will undergo a lung ultrasound pre- and post-extubation.
Looking for future studies?
Notify MeUp to 6 month
All sexes
Interventional
Not applicable
University of Minnesota, Minneapolis, Minnesota, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound of lungs
Time frame: 12 hours pre-extubation to 24 hours post extubation
Correlate the lung ultrasound score to the success of extubation, which is defined as remaining extubated for >72 hours. Ultrasound scores are measured on a 4-point scale (0=normal,3 = most abnormal).
Time frame: 12 hours pre-extubation to 24 hours post extubation
Ultrasound scores are measured on a 4-point scale (0=normal,3 = most abnormal).
Time frame: Up to 72 hours post-intubation
Length of time from extubation to re-intubation.
Time frame: 5 minutes before to 5 minutes after lung ultrasound
Measure of heart rate before and after ultrasound procedure
Time frame: 5 minutes before to 5 minutes after lung ultrasound
Measure of respiratory rate before and after ultrasound procedure
Time frame: 5 minutes before to 5 minutes after lung ultrasound
Measure of oxygen saturation before and after ultrasound procedure
Looking for future studies?
Notify MeUniversity of Wisconsin, Madison
Other
The Utility of Lung Ultrasound Scores to Determine Extubation Readiness in Neonates With Respiratory Distress on Mechanical Ventilation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07216053
Dyspnea, Female Urogenital Diseases and Pregnancy Complications
Hackensack, New Jersey, United States
View Trial DetailsNCT02262182
Lung Diseases, Pulmonary Atelectasis
Saint-Herblain, France
View Trial DetailsNCT07809971
Lung Diseases, Lung Ultrasound Score
Tanta, Q2x2+cp Tanta 2, Egypt, Egypt
View Trial DetailsNCT07609615
Atelectasis, Digestive System Diseases
İzmit, Kocaeli, Turkey (Türkiye)
View Trial Details